Bibliography

 

Assael, LA.  New Foundations in Understanding Osteonecrosis of the Jaw.  J Oral Maxillofac Surg 62:125-126, 2004.

 

            Durie, BGM, et.al.  Osteonecrosis of the Jaws in Myeloma:  Analysis of Risk Factors         Including Time Dependency of Aredeia and Zometa Use, Steroid Use and Underlying   Dental Problems.

 

            Durie, BGM, et. al. Osteonecrosis of the Jaws in Myeloma: Time Dependent Correlation      with Aredia and Zometa Use.  Blood 104:11, 2004.

 

            Durie, BGM, et.al.  Magnitude of Response With Myeloma Frontline Therapy Does Not       Predict Outcome: Importance of Time to Progression in Southwest Oncology Group       Chemotherapy Trials.  J Clin Oncol 10: 1857-1863, 2004.

 

            Durie, BGM, et.al.  Myeloma Management Guidelines: A Consensus Report from the          Scientific Advisors of the International Myeloma Foundation.  Hem J 4: 379-398, 2003.

 

Estilo, CL.  Osteonecrosis of the Maxilla and Mandible in Patients Treated with Bisphosphonates: A Retrospective Study.  J Clin Onc 22: 8008, 2004.

 

Kut, Victoria, et. al. Osteonecrosis of the Jaw in Myeloma Patients Receiving Pamidronate or Zoledronate. Blood 104:11, 2004.

 

Kut, Victoria, et.al., Post-Marketing Assessments of Serious Adverse Drug Reactions Reported by the Manufacturer to the FDA Differ Markedly with those from an Independent Pharmacovigilance Program: Empirical Findings Based on Bisphonate-Associated Osteonecrosis Descriptions by the Research on Adverse Events & Reports Project and the Product Manufacturer. Blood 104:11, 2004.

 

Marx, RE.  Letter to the editor: Pamidronate (Aredia) and Zoledronate (Zometa) Induced Avascular Necrosis of the Jaws: A Growing Epidemic. J Oral Maxillofac Surg 61: 1115-1117, 2003.

 

Migliorati, CA.  Letter to the Editor: Bisphosphanates and Oral Cavity Avascular Bone Necrosis.  J Clin Onc 21: 4253-4254, 2003.

 

Ruggiero, SL, et.al.  Osteonecrosis of the Jaws Associated With the Use of Bisphosphonates: A Review of 63 Cases.   J Oral Maxillofac Surg 62:527-534, 2004.

 

Schuster, Michael & Dymek Joanne. Oral Cavity Avascular Bone Necrosis – A Newly Recognized Complication of Intravenous (IV) Bisphosphonate Therapy in Cancer Patients. Blood 104:11, 2004.

 

Thakkar, Snehal, et. al. Bisphosphonate Therapy Associated with an Increased Incidence of Mandubular/Maxillary Osteomyelitis in Multiple Myeloma Patients. Blood 104:11, 2004.

 

Zarychanski, Ryan, et. al. Osteonecrosis of the Jaw Associated withPamidronate Therapy. Blood: 104:11, 2004.